MedTrace Logo

Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System

NCT04190602 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-07-10

No results posted yet for this study

Summary

The objective of this study is to evaluate the 5-year outcomes of participants with degenerative mitral valve disease treated with the NeoChord Artificial Chordae System, Model DS1000 in a post-market setting.

Conditions

  • Mitral Regurgitation
  • Mitral Valve Disease
  • Mitral Valve Insufficiency
  • Mitral Valve Prolapse
  • Heart Valve Diseases

Interventions

DEVICE

NeoChord Artificial Chordae Delivery System, Model DS1000

The intended use of the device is for the placement of artificial chordae when the natural chordae tendinae have become elongated or ruptured due to degenerative valve disease.

Sponsors & Collaborators

  • NeoChord

    lead INDUSTRY

Principal Investigators

  • Andres Beiras Fernandez, MD PhD · Johannes Gutenberg University Mainz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-09
Primary Completion
2022-10-31
Completion
2027-12-31

Countries

  • Germany
  • Greece
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04190602 on ClinicalTrials.gov